
Dacarbazine Suppliers & Bulk Manufacturers
Available Forms: IV Injection
Available Strengths: 100 mg/vial, 200 mg/vial
Reference Brands: DTIC-Dome®(EU & US)
Category: Oncology Cancer Care
Dacarbazine is available in IV Injection and strengths such as 100 mg/vial, 200 mg/vial. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Dacarbazine is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Dacarbazine can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Dacarbazine, marketed as DTIC-Dome® (by Bristol-Myers Squibb) and available as a generic in the US and EU, is an alkylating agent used in the treatment of malignant melanoma, Hodgkin’s lymphoma, and soft tissue sarcoma. Available in 100 mg and 200 mg vials for IV injection, Dacarbazine interferes with DNA replication, preventing cancer cell division. As a trusted oncology therapy, it is sourced from GMP-compliant suppliers and is a key treatment option for oncologists targeting aggressive cancers. Dacarbazine is widely available in global US and EU markets for hospital and clinic use.
Frequently Asked Questions
Related Products
Atezolizumab
Strength:
1200 mg/20 mL
Form: Intravenous infusion
Reference Brands: Tecentriq® (EU & US)
View DetailsDurvalumab
Strength:
120 mg/4 mL, 500 mg/10 mL
Form: Injection
Reference Brands: Imfinzi® (US & EU)
View DetailsSunitinib
Strength:
12.5 mg, 25 mg, 37.5 mg, 50 mg
Form: Tablet
Reference Brands: Sutent® (EU & US)
View DetailsQuick Response Guaranteed | Verified Suppliers